APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lacosamide Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lacosamide Drugs Market Outlook and Growth Opportunities 2026

27 December 2025208 pages

Choose your research edition.

Industry ResearchLacosamide Drugs Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Lacosamide Drugs Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Lacosamide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lacosamide Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Lacosamide Drugs Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Lacosamide Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lacosamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lacosamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lacosamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lacosamide Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lacosamide Drugs market include Zhejiang Huahai Pharmaceutical, CSPC Ouyi Pharmaceutical, Shijiazhuang No.4 Pharmaceutical, Shandong Loncom Pharmaceutical, Jiangxi Qingfeng Pharmaceutical, Jiangsu Haian Pharmaceutical, Jianmin Group, Hefei Yifan Biopharmaceuticals and Buchang Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lacosamide Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lacosamide Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lacosamide Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lacosamide Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Lacosamide Drugs Segment by Company

Zhejiang Huahai Pharmaceutical

CSPC Ouyi Pharmaceutical

Shijiazhuang No.4 Pharmaceutical

Shandong Loncom Pharmaceutical

Jiangxi Qingfeng Pharmaceutical

Jiangsu Haian Pharmaceutical

Jianmin Group

Hefei Yifan Biopharmaceuticals

Buchang Pharmaceutical

Beijing Sihuan Pharmaceutical

UCB Pharma

Teva

Sun Pharma

Sandoz

Mylan

Glenmark Pharmaceuticals

Camber Pharma

Aucta Pharma

Apotex

Actavis

Lacosamide Drugs Segment by Type

Oral Solution

Tablets

Injection

Lacosamide Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Lacosamide Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lacosamide Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lacosamide Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lacosamide Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Lacosamide Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lacosamide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lacosamide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lacosamide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lacosamide Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lacosamide Drugs industry.

Chapter 3: Detailed analysis of Lacosamide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lacosamide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lacosamide Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lacosamide Drugs Industry Trends Table 2. Lacosamide Drugs Industry Drivers Table 3. Lacosamide Drugs Industry Opportunities and Challenges Table 4. Lacosamide Drugs Industry Restraints Table 5. Global Lacosamide Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lacosamide Drugs Revenue Share by Company (2021-2026) Table 7. Global Lacosamide Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lacosamide Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Lacosamide Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lacosamide Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lacosamide Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Lacosamide Drugs Company, Product Type & Application Table 13. Global Lacosamide Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lacosamide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Solution Table 18. Significant Companies of Tablets Table 19. Significant Companies of Injection Table 20. Global Lacosamide Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Lacosamide Drugs Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Lacosamide Drugs Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Lacosamide Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Lacosamide Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Lacosamide Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Lacosamide Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Lacosamide Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Lacosamide Drugs Sales Value Share by Type (2021-2026) Table 29. Global Lacosamide Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital and Clinic Table 31. Significant Companies of Retail Pharmacies Table 32. Significant Companies of Other Table 33. Global Lacosamide Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Lacosamide Drugs Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Lacosamide Drugs Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Lacosamide Drugs Sales Volume Share by Application (2021-2026) Table 37. Global Lacosamide Drugs Sales Volume Share by Application (2027-2032) Table 38. Global Lacosamide Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Lacosamide Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Lacosamide Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Lacosamide Drugs Sales Value Share by Application (2021-2026) Table 42. Global Lacosamide Drugs Sales Value Share by Application (2027-2032) Table 43. Global Lacosamide Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Lacosamide Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Lacosamide Drugs Sales Market Share by Region (2021-2026) Table 46. Global Lacosamide Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Lacosamide Drugs Sales Market Share by Region (2027-2032) Table 48. Global Lacosamide Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Lacosamide Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Lacosamide Drugs Sales Value Share by Region (2021-2026) Table 51. Global Lacosamide Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Lacosamide Drugs Sales Value Share by Region (2027-2032) Table 53. Global Lacosamide Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Lacosamide Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Lacosamide Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Lacosamide Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Lacosamide Drugs Sales by Country (2021-2026) & (K Units) Table 58. Global Lacosamide Drugs Sales Market Share by Country (2021-2026) Table 59. Global Lacosamide Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Lacosamide Drugs Sales Market Share by Country (2027-2032) Table 61. Global Lacosamide Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Lacosamide Drugs Sales Value Market Share by Country (2021-2026) Table 63. Global Lacosamide Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Lacosamide Drugs Sales Value Market Share by Country (2027-2032) Table 65. Zhejiang Huahai Pharmaceutical Company Information Table 66. Zhejiang Huahai Pharmaceutical Business Overview Table 67. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Product Portfolio Table 69. Zhejiang Huahai Pharmaceutical Recent Development Table 70. CSPC Ouyi Pharmaceutical Company Information Table 71. CSPC Ouyi Pharmaceutical Business Overview Table 72. CSPC Ouyi Pharmaceutical Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. CSPC Ouyi Pharmaceutical Lacosamide Drugs Product Portfolio Table 74. CSPC Ouyi Pharmaceutical Recent Development Table 75. Shijiazhuang No.4 Pharmaceutical Company Information Table 76. Shijiazhuang No.4 Pharmaceutical Business Overview Table 77. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Product Portfolio Table 79. Shijiazhuang No.4 Pharmaceutical Recent Development Table 80. Shandong Loncom Pharmaceutical Company Information Table 81. Shandong Loncom Pharmaceutical Business Overview Table 82. Shandong Loncom Pharmaceutical Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Shandong Loncom Pharmaceutical Lacosamide Drugs Product Portfolio Table 84. Shandong Loncom Pharmaceutical Recent Development Table 85. Jiangxi Qingfeng Pharmaceutical Company Information Table 86. Jiangxi Qingfeng Pharmaceutical Business Overview Table 87. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Product Portfolio Table 89. Jiangxi Qingfeng Pharmaceutical Recent Development Table 90. Jiangsu Haian Pharmaceutical Company Information Table 91. Jiangsu Haian Pharmaceutical Business Overview Table 92. Jiangsu Haian Pharmaceutical Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Jiangsu Haian Pharmaceutical Lacosamide Drugs Product Portfolio Table 94. Jiangsu Haian Pharmaceutical Recent Development Table 95. Jianmin Group Company Information Table 96. Jianmin Group Business Overview Table 97. Jianmin Group Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Jianmin Group Lacosamide Drugs Product Portfolio Table 99. Jianmin Group Recent Development Table 100. Hefei Yifan Biopharmaceuticals Company Information Table 101. Hefei Yifan Biopharmaceuticals Business Overview Table 102. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Product Portfolio Table 104. Hefei Yifan Biopharmaceuticals Recent Development Table 105. Buchang Pharmaceutical Company Information Table 106. Buchang Pharmaceutical Business Overview Table 107. Buchang Pharmaceutical Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Buchang Pharmaceutical Lacosamide Drugs Product Portfolio Table 109. Buchang Pharmaceutical Recent Development Table 110. Beijing Sihuan Pharmaceutical Company Information Table 111. Beijing Sihuan Pharmaceutical Business Overview Table 112. Beijing Sihuan Pharmaceutical Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Beijing Sihuan Pharmaceutical Lacosamide Drugs Product Portfolio Table 114. Beijing Sihuan Pharmaceutical Recent Development Table 115. UCB Pharma Company Information Table 116. UCB Pharma Business Overview Table 117. UCB Pharma Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. UCB Pharma Lacosamide Drugs Product Portfolio Table 119. UCB Pharma Recent Development Table 120. Teva Company Information Table 121. Teva Business Overview Table 122. Teva Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Teva Lacosamide Drugs Product Portfolio Table 124. Teva Recent Development Table 125. Sun Pharma Company Information Table 126. Sun Pharma Business Overview Table 127. Sun Pharma Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Sun Pharma Lacosamide Drugs Product Portfolio Table 129. Sun Pharma Recent Development Table 130. Sandoz Company Information Table 131. Sandoz Business Overview Table 132. Sandoz Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Sandoz Lacosamide Drugs Product Portfolio Table 134. Sandoz Recent Development Table 135. Mylan Company Information Table 136. Mylan Business Overview Table 137. Mylan Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Mylan Lacosamide Drugs Product Portfolio Table 139. Mylan Recent Development Table 140. Glenmark Pharmaceuticals Company Information Table 141. Glenmark Pharmaceuticals Business Overview Table 142. Glenmark Pharmaceuticals Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Glenmark Pharmaceuticals Lacosamide Drugs Product Portfolio Table 144. Glenmark Pharmaceuticals Recent Development Table 145. Camber Pharma Company Information Table 146. Camber Pharma Business Overview Table 147. Camber Pharma Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Camber Pharma Lacosamide Drugs Product Portfolio Table 149. Camber Pharma Recent Development Table 150. Aucta Pharma Company Information Table 151. Aucta Pharma Business Overview Table 152. Aucta Pharma Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Aucta Pharma Lacosamide Drugs Product Portfolio Table 154. Aucta Pharma Recent Development Table 155. Apotex Company Information Table 156. Apotex Business Overview Table 157. Apotex Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Apotex Lacosamide Drugs Product Portfolio Table 159. Apotex Recent Development Table 160. Actavis Company Information Table 161. Actavis Business Overview Table 162. Actavis Lacosamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Actavis Lacosamide Drugs Product Portfolio Table 164. Actavis Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Lacosamide Drugs Distributors List Table 168. Lacosamide Drugs Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Lacosamide Drugs Product Image Figure 2. Global Lacosamide Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lacosamide Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lacosamide Drugs Sales (2021-2032) & (K Units) Figure 5. Global Lacosamide Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lacosamide Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Solution Image Figure 10. Tablets Image Figure 11. Injection Image Figure 12. Global Lacosamide Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Lacosamide Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Lacosamide Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Lacosamide Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Lacosamide Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Lacosamide Drugs Sales Value Share by Type (2021-2032) Figure 18. Hospital and Clinic Image Figure 19. Retail Pharmacies Image Figure 20. Other Image Figure 21. Global Lacosamide Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Lacosamide Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Lacosamide Drugs Sales Volume Share by Application (2021-2032) Figure 24. Global Lacosamide Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Lacosamide Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Lacosamide Drugs Sales Value Share by Application (2021-2032) Figure 27. Global Lacosamide Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Lacosamide Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Lacosamide Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Lacosamide Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Lacosamide Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. North America Lacosamide Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Lacosamide Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Lacosamide Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Lacosamide Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Lacosamide Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Lacosamide Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. South America Lacosamide Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Lacosamide Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Lacosamide Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Lacosamide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Lacosamide Drugs Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Lacosamide Drugs Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Solution
  • Tablets
  • Injection
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Shijiazhuang No.4 Pharmaceutical
  • Shandong Loncom Pharmaceutical
  • Jiangxi Qingfeng Pharmaceutical
  • Jiangsu Haian Pharmaceutical
  • Jianmin Group
  • Hefei Yifan Biopharmaceuticals
  • Buchang Pharmaceutical
  • Beijing Sihuan Pharmaceutical
  • UCB Pharma
  • Teva
  • Sun Pharma
  • Sandoz
  • Mylan
  • Glenmark Pharmaceuticals
  • Camber Pharma
  • Aucta Pharma
  • Apotex
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lacosamide Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Lacosamide Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Lacosamide Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lacosamide Drugs Market Dynamics
  1. 2.1 Lacosamide Drugs Industry Trends
  2. 2.2 Lacosamide Drugs Industry Drivers
  3. 2.3 Lacosamide Drugs Industry Opportunities and Challenges
  4. 2.4 Lacosamide Drugs Industry Restraints
3 Lacosamide Drugs Market by Company
  1. 3.1 Global Lacosamide Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Lacosamide Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Lacosamide Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Lacosamide Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Lacosamide Drugs Company Ranking (2024-2026)
  6. 3.6 Global Lacosamide Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Lacosamide Drugs Company Product Type and Application
  8. 3.8 Global Lacosamide Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lacosamide Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lacosamide Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lacosamide Drugs Market by Type
  1. 4.1 Lacosamide Drugs Type Introduction
  2. 4.1.1 Oral Solution
  3. 4.1.2 Tablets
  4. 4.1.3 Injection
  5. 4.2 Global Lacosamide Drugs Sales Volume by Type
  6. 4.2.1 Global Lacosamide Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Lacosamide Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Lacosamide Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Lacosamide Drugs Sales Value by Type
  10. 4.3.1 Global Lacosamide Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Lacosamide Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Lacosamide Drugs Sales Value Share by Type (2021-2032)
5 Lacosamide Drugs Market by Application
  1. 5.1 Lacosamide Drugs Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Lacosamide Drugs Sales Volume by Application
  6. 5.2.1 Global Lacosamide Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lacosamide Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lacosamide Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lacosamide Drugs Sales Value by Application
  10. 5.3.1 Global Lacosamide Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lacosamide Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lacosamide Drugs Sales Value Share by Application (2021-2032)
6 Lacosamide Drugs Regional Sales and Value Analysis
  1. 6.1 Global Lacosamide Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lacosamide Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Lacosamide Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Lacosamide Drugs Sales by Region (2027-2032)
  5. 6.3 Global Lacosamide Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lacosamide Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lacosamide Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lacosamide Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Lacosamide Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lacosamide Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Lacosamide Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lacosamide Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Lacosamide Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lacosamide Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lacosamide Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lacosamide Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Lacosamide Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lacosamide Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lacosamide Drugs Sales Value Share by Country, 2025 VS 2032
7 Lacosamide Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Lacosamide Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lacosamide Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lacosamide Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Lacosamide Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Lacosamide Drugs Sales by Country (2027-2032)
  6. 7.4 Global Lacosamide Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lacosamide Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lacosamide Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lacosamide Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lacosamide Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lacosamide Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Huahai Pharmaceutical
  2. 8.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Huahai Pharmaceutical Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Huahai Pharmaceutical Lacosamide Drugs Product Portfolio
  6. 8.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 8.2 CSPC Ouyi Pharmaceutical
  8. 8.2.1 CSPC Ouyi Pharmaceutical Company Information
  9. 8.2.2 CSPC Ouyi Pharmaceutical Business Overview
  10. 8.2.3 CSPC Ouyi Pharmaceutical Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CSPC Ouyi Pharmaceutical Lacosamide Drugs Product Portfolio
  12. 8.2.5 CSPC Ouyi Pharmaceutical Recent Developments
  13. 8.3 Shijiazhuang No.4 Pharmaceutical
  14. 8.3.1 Shijiazhuang No.4 Pharmaceutical Company Information
  15. 8.3.2 Shijiazhuang No.4 Pharmaceutical Business Overview
  16. 8.3.3 Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Product Portfolio
  18. 8.3.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
  19. 8.4 Shandong Loncom Pharmaceutical
  20. 8.4.1 Shandong Loncom Pharmaceutical Company Information
  21. 8.4.2 Shandong Loncom Pharmaceutical Business Overview
  22. 8.4.3 Shandong Loncom Pharmaceutical Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shandong Loncom Pharmaceutical Lacosamide Drugs Product Portfolio
  24. 8.4.5 Shandong Loncom Pharmaceutical Recent Developments
  25. 8.5 Jiangxi Qingfeng Pharmaceutical
  26. 8.5.1 Jiangxi Qingfeng Pharmaceutical Company Information
  27. 8.5.2 Jiangxi Qingfeng Pharmaceutical Business Overview
  28. 8.5.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Product Portfolio
  30. 8.5.5 Jiangxi Qingfeng Pharmaceutical Recent Developments
  31. 8.6 Jiangsu Haian Pharmaceutical
  32. 8.6.1 Jiangsu Haian Pharmaceutical Company Information
  33. 8.6.2 Jiangsu Haian Pharmaceutical Business Overview
  34. 8.6.3 Jiangsu Haian Pharmaceutical Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Haian Pharmaceutical Lacosamide Drugs Product Portfolio
  36. 8.6.5 Jiangsu Haian Pharmaceutical Recent Developments
  37. 8.7 Jianmin Group
  38. 8.7.1 Jianmin Group Company Information
  39. 8.7.2 Jianmin Group Business Overview
  40. 8.7.3 Jianmin Group Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jianmin Group Lacosamide Drugs Product Portfolio
  42. 8.7.5 Jianmin Group Recent Developments
  43. 8.8 Hefei Yifan Biopharmaceuticals
  44. 8.8.1 Hefei Yifan Biopharmaceuticals Company Information
  45. 8.8.2 Hefei Yifan Biopharmaceuticals Business Overview
  46. 8.8.3 Hefei Yifan Biopharmaceuticals Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hefei Yifan Biopharmaceuticals Lacosamide Drugs Product Portfolio
  48. 8.8.5 Hefei Yifan Biopharmaceuticals Recent Developments
  49. 8.9 Buchang Pharmaceutical
  50. 8.9.1 Buchang Pharmaceutical Company Information
  51. 8.9.2 Buchang Pharmaceutical Business Overview
  52. 8.9.3 Buchang Pharmaceutical Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Buchang Pharmaceutical Lacosamide Drugs Product Portfolio
  54. 8.9.5 Buchang Pharmaceutical Recent Developments
  55. 8.10 Beijing Sihuan Pharmaceutical
  56. 8.10.1 Beijing Sihuan Pharmaceutical Company Information
  57. 8.10.2 Beijing Sihuan Pharmaceutical Business Overview
  58. 8.10.3 Beijing Sihuan Pharmaceutical Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Sihuan Pharmaceutical Lacosamide Drugs Product Portfolio
  60. 8.10.5 Beijing Sihuan Pharmaceutical Recent Developments
  61. 8.11 UCB Pharma
  62. 8.11.1 UCB Pharma Company Information
  63. 8.11.2 UCB Pharma Business Overview
  64. 8.11.3 UCB Pharma Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 UCB Pharma Lacosamide Drugs Product Portfolio
  66. 8.11.5 UCB Pharma Recent Developments
  67. 8.12 Teva
  68. 8.12.1 Teva Company Information
  69. 8.12.2 Teva Business Overview
  70. 8.12.3 Teva Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Teva Lacosamide Drugs Product Portfolio
  72. 8.12.5 Teva Recent Developments
  73. 8.13 Sun Pharma
  74. 8.13.1 Sun Pharma Company Information
  75. 8.13.2 Sun Pharma Business Overview
  76. 8.13.3 Sun Pharma Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sun Pharma Lacosamide Drugs Product Portfolio
  78. 8.13.5 Sun Pharma Recent Developments
  79. 8.14 Sandoz
  80. 8.14.1 Sandoz Company Information
  81. 8.14.2 Sandoz Business Overview
  82. 8.14.3 Sandoz Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Sandoz Lacosamide Drugs Product Portfolio
  84. 8.14.5 Sandoz Recent Developments
  85. 8.15 Mylan
  86. 8.15.1 Mylan Company Information
  87. 8.15.2 Mylan Business Overview
  88. 8.15.3 Mylan Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Mylan Lacosamide Drugs Product Portfolio
  90. 8.15.5 Mylan Recent Developments
  91. 8.16 Glenmark Pharmaceuticals
  92. 8.16.1 Glenmark Pharmaceuticals Company Information
  93. 8.16.2 Glenmark Pharmaceuticals Business Overview
  94. 8.16.3 Glenmark Pharmaceuticals Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Glenmark Pharmaceuticals Lacosamide Drugs Product Portfolio
  96. 8.16.5 Glenmark Pharmaceuticals Recent Developments
  97. 8.17 Camber Pharma
  98. 8.17.1 Camber Pharma Company Information
  99. 8.17.2 Camber Pharma Business Overview
  100. 8.17.3 Camber Pharma Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Camber Pharma Lacosamide Drugs Product Portfolio
  102. 8.17.5 Camber Pharma Recent Developments
  103. 8.18 Aucta Pharma
  104. 8.18.1 Aucta Pharma Company Information
  105. 8.18.2 Aucta Pharma Business Overview
  106. 8.18.3 Aucta Pharma Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Aucta Pharma Lacosamide Drugs Product Portfolio
  108. 8.18.5 Aucta Pharma Recent Developments
  109. 8.19 Apotex
  110. 8.19.1 Apotex Company Information
  111. 8.19.2 Apotex Business Overview
  112. 8.19.3 Apotex Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Apotex Lacosamide Drugs Product Portfolio
  114. 8.19.5 Apotex Recent Developments
  115. 8.20 Actavis
  116. 8.20.1 Actavis Company Information
  117. 8.20.2 Actavis Business Overview
  118. 8.20.3 Actavis Lacosamide Drugs Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Actavis Lacosamide Drugs Product Portfolio
  120. 8.20.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lacosamide Drugs Value Chain Analysis
  2. 9.1.1 Lacosamide Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lacosamide Drugs Sales Mode & Process
  6. 9.2 Lacosamide Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lacosamide Drugs Distributors
  9. 9.2.3 Lacosamide Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst